Company: INVUP
Filing Date: 2025-05-14
Form Type: 10-Q
Source: 0001641172-25-010230
Chunk: 84

Company: Investview, Inc.
Filing Date: 2025-05-14
Form: 10-Q
Item: Part I, Item 8
Chunk 84
---
issory Note
with SSA under which SSA was to have advanced to us up to $1,500,000 before the end of 2021; however, SSA only provided advances of $1,200,000,
to date. The note bears interest at the rate of 0.11% per annum. The note was due and payable by January 31, 2022; however, has not yet
been repaid as we consider our legal options in light of SSA’s failure to complete its funding obligations, and the other damages
we sustained as a result of the actions of Mr. Cammarata. During the three months ended March 31, 2025, we recorded interest expense of
$330 on the note. The note was to have been secured by the pledge of 12,000,000 shares of our common stock; however, it remains unsecured
as the pledge of shares was not implemented at the closing of the loan.

    17

INVESTVIEW, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

AS OF March 31, 2025

(Unaudited)

The loans referenced in footnotes 1-3 above were advanced
under a Securities Purchase Agreement we entered into on April 27, 2020, with DBR Capital. Under the Securities Purchase Agreement (which
was subsequently amended and restated), DBR Capital agreed to advance up to $11 million to us in a series of up to five closings through
December 31, 2026, of which the amounts advanced covered in footnotes 1-3 above constituted the first three closings.

On February 28, 2025, we and DBR
Capital, entered into a Fifth Amendment to the now Amended and Restated Securities Purchase Agreement that extends the deadlines for the
fourth and fifth closings under that Agreement from December 31, 2024, to August 31, 2025 and December 31, 2026, respectively. The fourth
and fifth closings remain at the sole discretion of DBR Capital, and we cannot provide any assurance that they will occur when contemplated
or ever.

Other Related
Party Arrangements

On September 29, 2023, we closed on the purchase in
a private transaction of shares of our common stock under the terms of a Stock Purchase and Release Agreement dated September 18, 2023
(the “Romano/Raynor Agreement”). Under the